AR096552A1 - Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclico - Google Patents
Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclicoInfo
- Publication number
- AR096552A1 AR096552A1 ARP140102215A ARP140102215A AR096552A1 AR 096552 A1 AR096552 A1 AR 096552A1 AR P140102215 A ARP140102215 A AR P140102215A AR P140102215 A ARP140102215 A AR P140102215A AR 096552 A1 AR096552 A1 AR 096552A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- halogen
- amida
- same
- compound containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Se provee un compuesto que es útil como un agente para el tratamiento de cáncer de mama. Reivindicación 1: Un compuesto de la fórmula (1) o una de sus sales, en la fórmula, R¹ es arilo o heteroarilo que contiene nitrógeno monocíclico, cada uno de los cuales puede estar sustituido con grupos seleccionados del grupo que consiste en halógeno, alquilo inferior, -O-alquilo inferior, halógeno-alquilo inferior, -O- halógeno-alquilo inferior, -CN, dimetilamino y cicloalquilo; X es CH, N o C; ⁻ ⁻ ⁻ ⁻ ⁻ es i) un enlace simple en el caso donde X es CH o N y ii) un enlace doble en el caso donde X es C; Y es un grupo cíclico seleccionado del grupo de fórmulas (2) aquí, Y¹ es CRʰ o N; Y² es CRⁱ o N, siempre que Y¹ e Y² no sean N al mismo tiempo; Rᵃ, Rʰ y Rⁱ, que son iguales o diferentes entre sí, son H o halógeno; Rᵇ es H o alquilo inferior; Rᶜ es alquilo inferior; Y³ es CH o N; Rᵈ y Rᵉ son iguales o diferentes entre sí, son H, halógeno, alquilo inferior; Rᶠ es H o alquilo inferior; Y⁴ es O ó S; Y⁵ es CH o N; Y⁶ es CH o N; Rᵍ es H o alquilo inferior; R² es H o alquilo inferior; y R³ y R⁴, que son iguales o diferentes entre sí, son H, halógeno, alquilo inferior -O-alquilo inferior, halógeno-alquilo inferior, -O-halógeno-alquilo inferior cicloalquilo, o -CN, o R³ y R⁴ pueden formar 2,2-difluoro-1,3-benzodioxol mediante la unión entre sí con el anillo benceno al cual R³ y R⁴ están enlazados.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013122180 | 2013-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR096552A1 true AR096552A1 (es) | 2016-01-13 |
Family
ID=52022229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140102215A AR096552A1 (es) | 2013-06-10 | 2014-06-09 | Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclico |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9428501B2 (es) |
| EP (1) | EP3009424B1 (es) |
| JP (1) | JP5924453B2 (es) |
| KR (1) | KR20160018686A (es) |
| CN (1) | CN105308024B (es) |
| AR (1) | AR096552A1 (es) |
| AU (1) | AU2014279240A1 (es) |
| BR (1) | BR112015030248A2 (es) |
| CA (1) | CA2914982A1 (es) |
| EA (1) | EA028545B1 (es) |
| ES (1) | ES2661259T3 (es) |
| HK (1) | HK1220446A1 (es) |
| IL (1) | IL242997A (es) |
| MX (1) | MX2015016965A (es) |
| PH (1) | PH12015502744A1 (es) |
| PL (1) | PL3009424T3 (es) |
| PT (1) | PT3009424T (es) |
| SA (1) | SA515370253B1 (es) |
| SG (1) | SG11201510125WA (es) |
| TW (1) | TW201536771A (es) |
| WO (1) | WO2014199933A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016068099A1 (ja) * | 2014-10-28 | 2016-05-06 | 塩野義製薬株式会社 | Ａｍｐｋ活性化作用を有する複素環誘導体 |
| MA41158A (fr) * | 2014-12-09 | 2017-10-17 | Astellas Pharma Inc | Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif |
| MA41157A (fr) * | 2014-12-09 | 2017-10-17 | Astellas Pharma Inc | Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenant de l'azote bicyclique en tant que composant actif |
| JPWO2016093255A1 (ja) * | 2014-12-09 | 2017-09-21 | アステラス製薬株式会社 | 二環式含窒素芳香族ヘテロ環アミド化合物を有効成分とする医薬組成物 |
| US20190135747A1 (en) * | 2016-05-12 | 2019-05-09 | Regents Of The University Of Minnesota | Indole and indazole cyanocinnamate compounds and therapeutic uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19932314A1 (de) * | 1999-07-10 | 2001-01-11 | Merck Patent Gmbh | Benzofuranderivate |
| WO2002020008A1 (en) * | 2000-09-06 | 2002-03-14 | The Scripps Research Institute | Inhibitors of nadh:ubiquinone oxidoreductase |
| NZ570524A (en) * | 2006-03-28 | 2011-08-26 | High Point Pharmaceuticals Llc | Benzothiazoles having histamine H3 receptor activity |
| US7432255B2 (en) * | 2006-05-16 | 2008-10-07 | Hoffmann-La Roche Inc. | 1H-indol-5-yl-piperazin-1-yl-methanone derivatives |
| AU2008339572B2 (en) * | 2007-12-21 | 2012-05-10 | Astrazeneca Ab | Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| WO2009082667A1 (en) * | 2007-12-21 | 2009-07-02 | 3M Innovative Properties Company | Microbiological systems and methods of fluid sample analysis |
| WO2009132136A1 (en) * | 2008-04-23 | 2009-10-29 | Rigel Pharmaceuticals, Inc. | Carboxamide compounds for the treatment of metabolic disorders |
| ES2823350T3 (es) * | 2010-07-29 | 2021-05-06 | Rigel Pharmaceuticals Inc | Compuestos heterocíclicos que activan AMPK y métodos de uso de los mismos |
| US9409884B2 (en) | 2012-02-01 | 2016-08-09 | Rigel Pharmaceuticals, Inc. | 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them |
-
2014
- 2014-06-09 JP JP2015522759A patent/JP5924453B2/ja not_active Expired - Fee Related
- 2014-06-09 AU AU2014279240A patent/AU2014279240A1/en not_active Abandoned
- 2014-06-09 EA EA201592301A patent/EA028545B1/ru not_active IP Right Cessation
- 2014-06-09 TW TW103119885A patent/TW201536771A/zh unknown
- 2014-06-09 KR KR1020167000279A patent/KR20160018686A/ko not_active Application Discontinuation
- 2014-06-09 MX MX2015016965A patent/MX2015016965A/es active IP Right Grant
- 2014-06-09 EP EP14810281.7A patent/EP3009424B1/en active Active
- 2014-06-09 CA CA2914982A patent/CA2914982A1/en not_active Abandoned
- 2014-06-09 ES ES14810281.7T patent/ES2661259T3/es active Active
- 2014-06-09 PT PT148102817T patent/PT3009424T/pt unknown
- 2014-06-09 PL PL14810281T patent/PL3009424T3/pl unknown
- 2014-06-09 BR BR112015030248A patent/BR112015030248A2/pt active Search and Examination
- 2014-06-09 SG SG11201510125WA patent/SG11201510125WA/en unknown
- 2014-06-09 WO PCT/JP2014/065181 patent/WO2014199933A1/ja active Application Filing
- 2014-06-09 CN CN201480033143.0A patent/CN105308024B/zh active Active
- 2014-06-09 US US14/418,672 patent/US9428501B2/en active Active
- 2014-06-09 AR ARP140102215A patent/AR096552A1/es unknown
-
2015
- 2015-12-09 SA SA515370253A patent/SA515370253B1/ar unknown
- 2015-12-09 PH PH12015502744A patent/PH12015502744A1/en unknown
- 2015-12-09 IL IL242997A patent/IL242997A/en not_active IP Right Cessation
-
2016
- 2016-07-15 HK HK16108380.3A patent/HK1220446A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA028545B1 (ru) | 2017-11-30 |
| IL242997A (en) | 2017-04-30 |
| PH12015502744A1 (en) | 2016-03-21 |
| EP3009424A4 (en) | 2016-11-30 |
| PT3009424T (pt) | 2018-01-16 |
| CA2914982A1 (en) | 2014-12-18 |
| HK1220446A1 (zh) | 2017-05-05 |
| WO2014199933A1 (ja) | 2014-12-18 |
| SG11201510125WA (en) | 2016-01-28 |
| CN105308024A (zh) | 2016-02-03 |
| US20150266869A1 (en) | 2015-09-24 |
| US9428501B2 (en) | 2016-08-30 |
| PL3009424T3 (pl) | 2018-03-30 |
| ES2661259T3 (es) | 2018-03-28 |
| EA201592301A1 (ru) | 2016-05-31 |
| TW201536771A (zh) | 2015-10-01 |
| CN105308024B (zh) | 2017-10-27 |
| JPWO2014199933A1 (ja) | 2017-02-23 |
| JP5924453B2 (ja) | 2016-05-25 |
| EP3009424B1 (en) | 2017-12-20 |
| MX2015016965A (es) | 2016-04-25 |
| KR20160018686A (ko) | 2016-02-17 |
| SA515370253B1 (ar) | 2017-03-06 |
| EP3009424A1 (en) | 2016-04-20 |
| BR112015030248A2 (pt) | 2017-07-25 |
| AU2014279240A1 (en) | 2016-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR106763A1 (es) | Oxadiazoles sustituidos para combatir hongos fitopatógenos | |
| AR099995A1 (es) | Piridilamidinas fungicidas | |
| AR106605A1 (es) | Oxadiazoles sustituidos para combatir hongos fitopatógenos | |
| AR096552A1 (es) | Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclico | |
| AR095311A1 (es) | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de idh mutante | |
| CR20170564A (es) | Nuevos derivados hidroxiéster, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| AR100645A1 (es) | Derivados de pirazolo-pirimidina | |
| AR095326A1 (es) | Heterociclos tricíclicos como inhibidores de la proteína bet | |
| AR080057A1 (es) | Piridinas disustituidas como anticancerigenos | |
| AR090760A1 (es) | Compuestos de benzotiazol y su uso contra el virus de hiv | |
| AR096979A1 (es) | Derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| SV2017005405A (es) | Compuestos y composiciones como inhibidores de quinasa raf | |
| AR100315A1 (es) | Compuestos de piridina sustituida que tienen acción herbicida | |
| AR097325A1 (es) | Pirroles anillados | |
| AR111983A1 (es) | ANILLOS 6 - 5 FUSIONADOS COMO INHIBIDORES DE C5a | |
| AR093825A1 (es) | COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARINICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENERGICO | |
| CO2018003367A2 (es) | Benzamidas sustituidas con isoxazolina y análogos como insecticidas | |
| AR092170A1 (es) | Proceso para la fabricacion de benzoxazinonas | |
| AR089753A1 (es) | Derivados de amida heterociclicos como antagonistas del receptor p2x7 | |
| PE20160880A1 (es) | Compuestos de triazolona y usos de los mismos | |
| AR105549A1 (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
| AR097932A1 (es) | Antagonista del receptor de somatostatina del subtipo 5 (sstr5) | |
| AR098818A1 (es) | Derivados de oxindol, preparación de los mismos y uso terapéutico de los mismos | |
| SV2016005293A (es) | Compuestos de azol amido-sustituidos como inhibidores de tnks1 y/o tnks2 | |
| DOP2014000178A (es) | Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |